Financhill
Sell
32

SKWD Quote, Financials, Valuation and Earnings

Last price:
$51.40
Seasonality move :
8.97%
Day range:
$50.38 - $51.66
52-week range:
$29.40 - $55.62
Dividend yield:
0%
P/E ratio:
15.56x
P/S ratio:
1.91x
P/B ratio:
2.57x
Volume:
221.1K
Avg. volume:
252.6K
1-year change:
51.61%
Market cap:
$2B
Revenue:
$895.4M
EPS (TTM):
$3.28

Analysts' Opinion

  • Consensus Rating
    Skyward Specialty Insurance Group has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of --, Skyward Specialty Insurance Group has an estimated upside of 2.75% from its current price of $51.44.
  • Price Target Downside
    According to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $51.44.

Fair Value

  • According to the consensus of 7 analysts, Skyward Specialty Insurance Group has 2.75% upside to fair value with a price target of -- per share.

SKWD vs. S&P 500

  • Over the past 5 trading days, Skyward Specialty Insurance Group has underperformed the S&P 500 by -3.75% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Skyward Specialty Insurance Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Skyward Specialty Insurance Group has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Skyward Specialty Insurance Group reported revenues of $302M.

Earnings Growth

  • Skyward Specialty Insurance Group has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Skyward Specialty Insurance Group reported earnings per share of $0.89.
Enterprise value:
1.1B
EV / Invested capital:
1.19x
Price / LTM sales:
1.91x
EV / EBIT:
5.98x
EV / Revenue:
1.00x
PEG ratio (5yr expected):
0.19x
EV / Free cash flow:
2.74x
Price / Operating cash flow:
5.26x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
4.17%
Net Income Margin (TTM):
12.24%
Return On Equity:
19.6%
Return On Invested Capital:
16.61%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $592.5M $835.4M $1.1B $239.2M $302M
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS $0.25 $1.78 $3.28 $0.57 $0.89
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets -- -- $1B $2.2B $2.3B
Total Assets -- -- $2.3B $2.9B $3.6B
Current Liabilities -- -- $184.6M $226.2M $274M
Total Liabilities -- -- $1.9B $2.3B $2.8B
Total Equity -- -- $399.8M $535.4M $797.5M
Total Debt -- -- $128.6M $128.7M $119M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -- $302.6M $402.9M $110.1M $168M
Cash From Investing -- -$372.9M -$413.9M -$109.7M -$130.1M
Cash From Financing -- $67.5M $59.2M $1.1M $5.2M
Free Cash Flow -- $300.2M $396.6M $111.3M $167.6M
SKWD
Sector
Market Cap
$2B
$700.3M
Price % of 52-Week High
91.77%
88.31%
Dividend Yield
0%
2.2%
Shareholder Yield
-4.06%
3.87%
1-Year Price Total Return
50.38%
7.75%
Beta (5-Year)
--
0.737
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $50.95
200-day SMA
Buy
Level $40.78
Bollinger Bands (100)
Buy
Level 39.42 - 50.4
Chaikin Money Flow
Buy
Level 11.6M
20-day SMA
Sell
Level $52.14
Relative Strength Index (RSI14)
Buy
Level 52.14
ADX Line
Sell
Level 21.73
Williams %R
Neutral
Level -66.3524
50-day SMA
Buy
Level $49.61
MACD (12, 26)
Buy
Level 0.19
25-day Aroon Oscillator
Sell
Level -44
On Balance Volume
Neutral
Level 24.7M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.4407)
Sell
CA Score (Annual)
Level (-1.4904)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.6695)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers’ compensation.

Stock Forecast FAQ

In the current month, SKWD has received 5 Buy ratings 2 Hold ratings, and 0 Sell ratings. The SKWD average analyst price target in the past 3 months is --.

  • Where Will Skyward Specialty Insurance Group Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Skyward Specialty Insurance Group share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Skyward Specialty Insurance Group?

    Analysts are divided on their view about Skyward Specialty Insurance Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Skyward Specialty Insurance Group is a Sell and believe this share price will drop from its current level to --.

  • What Is Skyward Specialty Insurance Group's Price Target?

    The price target for Skyward Specialty Insurance Group over the next 1-year time period is forecast to be -- according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is SKWD A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Skyward Specialty Insurance Group is a Buy. 5 of 7 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of SKWD?

    You can purchase shares of Skyward Specialty Insurance Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Skyward Specialty Insurance Group shares.

  • What Is The Skyward Specialty Insurance Group Share Price Today?

    Skyward Specialty Insurance Group was last trading at $51.40 per share. This represents the most recent stock quote for Skyward Specialty Insurance Group. Yesterday, Skyward Specialty Insurance Group closed at $51.44 per share.

  • How To Buy Skyward Specialty Insurance Group Stock Online?

    In order to purchase Skyward Specialty Insurance Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 49.62% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is up 10.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock